Keyphrases
In Vitro Study
100%
Lopinavir
96%
Azithromycin
88%
Indonesia
74%
COVID-19
73%
Drug Combination
72%
Stem Cells
68%
Stem Cell Metabolites
64%
Hydroxychloroquine
64%
SARS-CoV-2 Virus
55%
Adipose-derived Mesenchymal Stem Cells (ADMSCs)
53%
Doxycycline
44%
Mesenchymal Stem Cells
42%
Platelet-derived Growth factor-BB (PDGF-BB)
39%
Skin Regeneration
38%
Surabaya
38%
Bone Defect
36%
Growth Factors
36%
Antiviral Agents
36%
Antibiotics
36%
Dual Drug
34%
Amniotic Mesenchymal Stem Cells
32%
Metabolic Products
32%
Skin Mesenchymal Stem Cells
32%
Collagen
32%
Platelet-rich Fibrin
32%
Placenta
32%
Clinical Outcomes
32%
Amniotic Membrane
32%
Non-adherence
32%
Viral Inactivation
32%
Epidermal Growth Factor
32%
Counseling
32%
Natural Killer Cells
32%
Rattus Norvegicus
32%
Osteogenesis
32%
COVID-19 Infection
32%
Cellulose Acetate
32%
Chitosan Scaffold
32%
Osteogenesis Induction
32%
Distribution Pattern
32%
Wound Dressing Material
32%
Moderate COVID-19
32%
Multicenter Clinical Trial
32%
Hematopoietic Stem Cells
32%
Randomized Double-blind
32%
Liposomal
32%
Fibroblast Growth Factor 1 (FGF1)
32%
Antiretroviral Adherence
32%
Factor Level
32%
Pharmacology, Toxicology and Pharmaceutical Science
Lopinavir Plus Ritonavir
96%
Azithromycin
88%
Combination Drug
71%
SARS Coronavirus
67%
Infection
64%
Hydroxychloroquine
64%
Doxycycline
44%
Diseases
40%
Bone Defect
36%
Coronavirinae
36%
Liposome
35%
Alkaline Phosphatase
32%
Antivirus Agent
32%
Rattus norvegicus
32%
Clinical Study
32%
Acne
32%
Antibiotics
32%
Chitosan
32%
Hyaluronic Acid
32%
Egg Lecithin
30%
Clinical Trial
23%
Phospholipid
22%
Octadecylamine
16%
Cholic Acid
16%
Cytotoxicity
15%
Glycerophosphoethanolamine
13%
Interleukin 6
13%
Interleukin 10
13%
Tumor Necrosis Factor
13%
Favipiravir
12%
Growth Factor
11%
Biocompatibility
9%
Treatment Group
8%
Pharmacotherapy
8%
Prevalence
8%
Combination Therapy
8%
Clarithromycin
8%
IC50
8%
Metal Oxide
8%
Hydration
7%
Inflammation
7%
Anti-Inflammatory Drug
7%
Dyspnea
7%